Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Angiotensin II type 2 (AT-2) receptor | Starlite/ChEMBL | References |
Oryctolagus cuniculus | Angiotensin II type 1a (AT-1a) receptor | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | GMP reductase | 0.0119 | 0.238 | 0.182 |
Trypanosoma cruzi | GMP reductase | 0.0287 | 1 | 1 |
Brugia malayi | inosine-5'-monophosphate dehydrogenase | 0.0119 | 0.238 | 0.182 |
Toxoplasma gondii | IMP dehydrogenas | 0.0287 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | IMP dehydrogenase | 0.0287 | 1 | 0.5 |
Plasmodium falciparum | inosine-5'-monophosphate dehydrogenase | 0.027 | 0.9226 | 1 |
Loa Loa (eye worm) | GMP reductase | 0.0119 | 0.238 | 0.182 |
Onchocerca volvulus | Putative GMP reductase | 0.0119 | 0.238 | 0.5 |
Mycobacterium leprae | Probable inosine-5'-monophosphate dehydrogenase GuaB3 (IMP dehydrogenase 2) (inosinic acid dehydrogenase) (inosinate dehydrogena | 0.0151 | 0.3808 | 0.0954 |
Leishmania major | p450 reductase, putative | 0.0133 | 0.2992 | 0.0891 |
Leishmania major | guanosine monophosphate reductase | 0.0287 | 1 | 1 |
Trypanosoma brucei | inosine-5'-monophosphate dehydrogenase | 0.0287 | 1 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0133 | 0.2992 | 0.2476 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0133 | 0.2992 | 0.2992 |
Brugia malayi | inosine-5'-monophosphate dehydrogenase | 0.0119 | 0.238 | 0.182 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0287 | 1 | 1 |
Echinococcus multilocularis | inosine 5' monophosphate dehydrogenase 2 | 0.0287 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0133 | 0.2992 | 0.2476 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0133 | 0.2992 | 0.0891 |
Mycobacterium tuberculosis | Probable inosine-5'-monophosphate dehydrogenase GuaB2 (imp dehydrogenase) (inosinic acid dehydrogenase) (inosinate dehydrogenase | 0.0287 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0118 | 0.2306 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0133 | 0.2992 | 0.2476 |
Plasmodium vivax | inosine-5'-monophosphate dehydrogenase, putative | 0.027 | 0.9226 | 1 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0133 | 0.2992 | 0.2476 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0287 | 1 | 1 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0133 | 0.2992 | 0.2476 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0133 | 0.2992 | 0.0991 |
Mycobacterium leprae | Probable inosine-5'-monophosphate dehydrogenase GuaB2 (IMP dehydrogenase) (IMPDH) (IMPD) | 0.0287 | 1 | 1 |
Leishmania major | inosine-5-monophosphate dehydrogenase | 0.0287 | 1 | 1 |
Trypanosoma brucei | GMP reductase | 0.0287 | 1 | 1 |
Trypanosoma cruzi | inosine-5'-monophosphate dehydrogenase, putative | 0.0287 | 1 | 1 |
Brugia malayi | flavodoxin family protein | 0.0133 | 0.2992 | 0.2476 |
Trypanosoma cruzi | GMP reductase | 0.0287 | 1 | 1 |
Echinococcus granulosus | inosine 5' monophosphate dehydrogenase 2 | 0.0287 | 1 | 1 |
Schistosoma mansoni | inosine-5-monophosphate dehydrogenase | 0.0287 | 1 | 1 |
Chlamydia trachomatis | sulfite reductase | 0.0082 | 0.0685 | 0.5 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0082 | 0.0685 | 0.0685 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.2992 | 0.2476 |
Mycobacterium ulcerans | inosine 5-monophosphate dehydrogenase | 0.0136 | 0.3155 | 0.0232 |
Giardia lamblia | Hypothetical protein | 0.0118 | 0.2306 | 0.5 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0133 | 0.2992 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0133 | 0.2992 | 0.2476 |
Loa Loa (eye worm) | IMP dehydrogenase 1 | 0.0287 | 1 | 1 |
Mycobacterium ulcerans | inosine 5-monophosphate dehydrogenase | 0.027 | 0.9226 | 0.8895 |
Mycobacterium ulcerans | inosine 5'-monophosphate dehydrogenase | 0.0287 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 2.4 nM | In vitro inhibitory activity against angiotensin II rabbit aorta AT1 receptor using radioligand [125I]-Sar Ile-AII | ChEMBL. | 8064808 |
IC50 (binding) | = 2.4 nM | In vitro inhibitory activity against angiotensin II rabbit aorta AT1 receptor using radioligand [125I]-Sar Ile-AII | ChEMBL. | 8064808 |
IC50 (binding) | = 150 nM | In vitro inhibitory activity against angiotensin II rat midbrain AT2 receptor using radioligand [125I]-Sar Ile-AII | ChEMBL. | 8064808 |
IC50 (binding) | = 150 nM | In vitro inhibitory activity against angiotensin II rat midbrain AT2 receptor using radioligand [125I]-Sar Ile-AII | ChEMBL. | 8064808 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.